Intracranial Aneurysm Market Intelligence Report - Global Forecast to 2027

Intracranial Aneurysm Market Intelligence Report - Global Forecast to 2027

The Global Intracranial Aneurysm Market is projected to reach USD 2,906.68 million by 2027 from USD 913.82 million in 2021, at a CAGR 21.27% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Intracranial Aneurysm Market size was estimated at USD 309.88 million in 2021 and expected to reach USD 369.41 million in 2022, at a CAGR 20.96% to reach USD 971.11 million by 2027.
• The Asia-Pacific Intracranial Aneurysm Market size was estimated at USD 212.31 million in 2021 and expected to reach USD 257.45 million in 2022, at a CAGR 21.64% to reach USD 688.05 million by 2027.
• The Europe, Middle East & Africa Intracranial Aneurysm Market size was estimated at USD 391.61 million in 2021 and expected to reach USD 470.73 million in 2022, at a CAGR 21.30% to reach USD 1,247.52 million by 2027.

Market Segmentation & Coverage:

The report on intracranial aneurysm identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the intracranial aneurysm to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

• Artery Occlusion & Bypass
• Endovascular Coiling
• Flow Diverters
• Surgical Clipping

Indication:

• Ruptured Aneurysm
• Unruptured Aneurysm

End User:

• Clinics
• Hospitals

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • Arizona
    • California
    • Florida
    • Illinois
    • Massachusetts
    • New Jersey
    • North Carolina
    • Ohio
    • Pennsylvania
    • Texas
    • Washington
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Abbvie Inc.
• Acandis GmbH
• Adeor Medical AG
• B. Braun Melsungen AG
• Balt Extrusion S.A.
• Bayer AG
• Bristol-Myers Squibb Company
• Cardiatis, S.A.
• Evasc Medical Systems Corp
• Integra Lifesciences Holdings Corporation
• Johnson & Johnson Services, Inc.
• Kaneka Corporation
• Medtronic PLC
• Merck & Co., Inc.
• Microport Scientific Corporation
• Mizuho Medical Co,Ltd.
• Penumbra, Inc.
• Pfizer Inc.
• Stryker Corporation
• Terumo Corporation